ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Determinants of antibiotics misuse and overuse in high-risk countries in the European region: a multidisciplinary Delphi study.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sialoendoscopy with Intraductal Irrigation in Chronic Salivary Gland Disease: A Minimally Invasive, Antibiotic-Sparing Strategy.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAntimicrobial-resistant (AMR) related deaths were predicted to have the greatest impact in Türkiye, Greece, Italy, and Portugal by 2050. Outpatient misuse and overuse of antibiotics are major contributors. We aimed to identify the underlying causes of inappropriate antibiotic use in outpatient settings and to develop context-specific, expert-driven solutions.
methodsA two-round e-Delphi process was used among experts, including primary care physicians, infectious disease specialists, ENT doctors, emergency medicine physicians, public health professionals, pharmacists, and policymakers working in outpatient settings. A 7-point Likert scale assessed 47 potential causes and 25 proposed solutions. Consensus was defined using interquartile range, median, and percent agreement. Expert agreement was assessed using Kendall's W.
results109 experts from 52 cities in Greece, Italy, Portugal, and Türkiye participated, with a response rate of 88% (109/124) in both rounds. Consensus was reached on 6 (12.76%) causes and 21 solutions (84%). Patient-related factors, such as low health literacy, limited awareness of AMR, and expectations of rapid recovery, emerged as major contributors. System-level shortcomings, including weak regulatory enforcement and underfunded stewardship efforts, were also identified. High-priority solutions included stricter regulation of non-prescription antibiotic sales, updated national prescribing guidelines, and integration of clinical decision-support tools.
conclusionAddressing AMR in high-risk countries requires both systemic reform and individual behaviour change. While common challenges exist, national differences require tailored strategies, such as healthcare accessibility, appointment length, and physician-patient communication. Sharing best practices is critical, but context-sensitive strategies are essential to effectively address this global health threat.
Indexed as
Identifiers
41236575What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.